Comparative Pharmacology
Head-to-head clinical analysis: CHROMIC CHLORIDE versus CHROMIC CHLORIDE IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHROMIC CHLORIDE versus CHROMIC CHLORIDE IN PLASTIC CONTAINER.
CHROMIC CHLORIDE vs CHROMIC CHLORIDE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chromic chloride dissociates to provide trivalent chromium (Cr3+), a component of glucose tolerance factor (GTF) that potentiates insulin action by increasing insulin receptor binding, insulin receptor number, and insulin internalization. It also activates insulin receptor tyrosine kinase activity and enhances downstream signaling pathways (e.g., PI3K/Akt), thereby improving glucose uptake and metabolism.
Chromium is an essential trace element that potentiates insulin action, improves glucose tolerance, and enhances protein and lipid metabolism. It is a component of chromodulin, a low-molecular-weight chromium-binding substance that binds to the insulin receptor and activates tyrosine kinase activity, increasing insulin sensitivity.
10-15 mcg/kg intravenously over 8-24 hours as part of total parenteral nutrition (TPN). Typical adult dose: 10-15 mcg daily.
Intravenous: 10-15 mcg/kg/day of elemental chromium added to parenteral nutrition.
None Documented
None Documented
Terminal half-life: approximately 18-24 hours for systemic clearance, but tissue retention half-life may be prolonged (weeks) due to intracellular binding.
The terminal elimination half-life of chromium (as Cr(III)) from plasma is approximately 15-41 hours, with a mean of about 24 hours. This long half-life reflects slow clearance from deep tissue compartments.
Renal: ~60% (20-60% as unchanged chromium); Biliary/fecal: ~40% (unabsorbed fraction and small amount in bile); total body elimination is slow due to tissue binding.
Renal excretion of absorbed chromium is the primary route of elimination, accounting for approximately 60-80% of the absorbed dose. Biliary/fecal excretion accounts for <10%.
Category C
Category C
Trace Element Supplement
Trace Element Supplement